DK0900218T3 - Heterocykliske forbindelser - Google Patents

Heterocykliske forbindelser

Info

Publication number
DK0900218T3
DK0900218T3 DK97925405T DK97925405T DK0900218T3 DK 0900218 T3 DK0900218 T3 DK 0900218T3 DK 97925405 T DK97925405 T DK 97925405T DK 97925405 T DK97925405 T DK 97925405T DK 0900218 T3 DK0900218 T3 DK 0900218T3
Authority
DK
Denmark
Prior art keywords
pct
heterocyclic compounds
sec
date
pub
Prior art date
Application number
DK97925405T
Other languages
English (en)
Inventor
Leander Merritt
Jon K Reel
Richard L Simon
Celia A Whitesitt
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0900218T3 publication Critical patent/DK0900218T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Earth Drilling (AREA)
  • Stereophonic System (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
DK97925405T 1996-04-23 1997-04-23 Heterocykliske forbindelser DK0900218T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1600896P 1996-04-23 1996-04-23
PCT/US1997/006699 WO1997040044A1 (en) 1996-04-23 1997-04-23 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
DK0900218T3 true DK0900218T3 (da) 2002-09-02

Family

ID=21774852

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97925405T DK0900218T3 (da) 1996-04-23 1997-04-23 Heterocykliske forbindelser

Country Status (10)

Country Link
US (1) US6117883A (da)
EP (1) EP0900218B1 (da)
JP (1) JP2000509046A (da)
AT (1) ATE221066T1 (da)
AU (1) AU3055397A (da)
CA (1) CA2250873A1 (da)
DE (1) DE69714247T2 (da)
DK (1) DK0900218T3 (da)
ES (1) ES2180998T3 (da)
WO (1) WO1997040044A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6919447B2 (en) * 2001-06-06 2005-07-19 Weyerhaeuser Company Hypochlorite free method for preparation of stable carboxylated carbohydrate products
US7001483B2 (en) * 2003-08-05 2006-02-21 Weyerhaeuser Company Apparatus for making carboxylated pulp fibers
US20050028953A1 (en) * 2003-08-05 2005-02-10 Severeid David E. Methods for making carboxylated pulp fibers
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1994018201A1 (en) * 1993-02-12 1994-08-18 Sankyo Company, Limited Isoxazoleoxy derivative
DE69406836T2 (de) * 1993-04-21 1998-06-25 Tosoh Corp Teilweise als Fungizide verwendbare 3,4-Dioxy-1,2,5-thiadiazole
JPH07188017A (ja) * 1993-09-30 1995-07-25 Souyaku Gijutsu Kenkyusho:Kk チアジアゾール誘導体を含有する抗ウイルス剤
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5646289A (en) * 1994-10-24 1997-07-08 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
US5998434A (en) * 1995-12-06 1999-12-07 Eli Lilly And Company Composition for treating pain
WO1997034899A1 (en) * 1996-03-19 1997-09-25 Novo Nordisk A/S Heterocyclic compounds and their preparation and use

Also Published As

Publication number Publication date
US6117883A (en) 2000-09-12
EP0900218A4 (en) 2001-05-23
EP0900218B1 (en) 2002-07-24
EP0900218A1 (en) 1999-03-10
ES2180998T3 (es) 2003-02-16
AU3055397A (en) 1997-11-12
DE69714247T2 (de) 2003-01-23
WO1997040044A1 (en) 1997-10-30
CA2250873A1 (en) 1997-10-30
ATE221066T1 (de) 2002-08-15
DE69714247D1 (de) 2002-08-29
JP2000509046A (ja) 2000-07-18

Similar Documents

Publication Publication Date Title
ATE219064T1 (de) Piperazinderivative als tachykinin antagonisten
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
ATE201016T1 (de) Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten
ID29230A (id) Alat kompensasi tekanan untuk wadah dua-bagian
ATE273956T1 (de) Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten
AP9801312A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist.
NO983002L (no) Vitronectin-reseptor-antagonister
BG103548A (en) Vitronectine receptor antagonists
DE69734321D1 (de) Non-peptidische vasopressin via antagonisten
TR200100885T2 (tr) 2-Metil-tieno-benzodiazepin formülasyonu
PT918744E (pt) Separacao racemica da cetamina
ATE180350T1 (de) Klemmeinrichtung und zugehörige halteeinrichtung
BR9708347A (pt) Compostos de tetrahidorbeta-carbonila
WO2002039118A8 (en) Screening methods for bone morphogenetic mimetics
DK0900218T3 (da) Heterocykliske forbindelser
ATE288909T1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
IT1285777B1 (it) Processo di biotrasformazione di composti colchicinoidi nei corrispondenti 3-glicosilderivati
ATE215084T1 (de) Imidazopyridin-azolidinone
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
EP0971885A4 (en) METHOD FOR PRODUCING INDAN-LIKE CONNECTIONS
WO2001012838A3 (en) Compounds which modulate the activity of an lpa receptor
DK0914129T3 (da) Anvendelse af aspirochlor eller derivater deraf som immunosuppresive midler
ES2154457T3 (es) Derivados de ciclohexadieno sustituidos con dimetilo.
UY24621A1 (es) Nuevos compuestos
ES1030348U (es) Hito prefabricado con anclaje.